MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy (OU-SCC-PROBX)
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy for the Detection of Clinically Significant Prostate Cancer
Sponsor: University of Oklahoma
A observational or N/A phase clinical study on Prostate Cancer, this trial is ongoing. The trial is conducted by University of Oklahoma and has accumulated 13 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Jun 2025 — Nov 2025 [monthly]
Active Not Recruiting
-
Apr 2025 — Jun 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2024 — Mar 2024 [monthly]
Recruiting
-
Nov 2023 — Jan 2024 [monthly]
Recruiting
-
Jun 2023 — Nov 2023 [monthly]
Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Oklahoma
For direct contact, visit the study record on ClinicalTrials.gov .